Guard Therapeutics International AB (publ) (STO:GUARD)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.580
-0.020 (-1.25%)
At close: Mar 4, 2026

STO:GUARD Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
11.749.929.158.825.96
Research & Development
9690.33105.77104.8175.33
Operating Expenses
107.74100.24114.92113.6381.28
Operating Income
-107.74-100.24-114.92-113.63-81.28
Interest Expense
-2.23-0.01-0.01-0-0
Interest & Investment Income
0.581.312.20.140.02
Currency Exchange Gain (Loss)
0.542.88-0.590.65-0.77
Other Non Operating Income (Expenses)
0-000-0
Pretax Income
-108.85-96.07-113.32-112.84-82.03
Net Income
-108.85-96.07-113.32-112.84-82.03
Net Income to Common
-108.85-96.07-113.32-112.84-82.03
Shares Outstanding (Basic)
18111074
Shares Outstanding (Diluted)
18111074
Shares Change (YoY)
61.72%10.82%42.77%57.95%34.53%
EPS (Basic)
-6.04-8.62-11.26-16.01-18.39
EPS (Diluted)
-6.04-8.62-11.26-16.01-18.39
Free Cash Flow
-109.35-94.75-116.05-102.14-77.59
Free Cash Flow Per Share
-6.06-8.50-11.53-14.49-17.39
EBITDA
--100.23-114.91-113.61-81.27
D&A For EBITDA
-0.020.020.020.02
EBIT
-107.74-100.24-114.92-113.63-81.28
Source: S&P Global Market Intelligence. Standard template. Financial Sources.